Table 4 |
|
|
THE SHARE OF p16INK4a-NEGATIVE SAMPLES AMONG CERVICAL CARCINOMAS (LITERATURE DATA) |
|
|
Research group (reference) |
The share (per cent) of p16INK4a-negative samples |
|
|
|
|
among adenocarcinomas: |
|
|
Lu et al, 1998 (7) |
17/40 (42.5%) |
|
Sano et al, 1998 (8) |
4/15 (26.7%) |
|
Milde-Langosch et al, 2001(10) |
8/58 (13,8%) |
|
Klaes et al, 2001(9) |
1/7 (14.3%) |
|
Saqi et al, 2002 (13) |
0/2 (0%) |
|
Murphy et al, 2003 (14) |
0/2 (0%) |
|
Negri et al, 2003 (15) |
0/18 (0%) |
|
Agoff et al, 2003 (16) |
2/7 (28.6 %) |
|
Present study |
0/5 (0%) |
|
among squamous cell carcinomas: |
|
|
Wong et al, 1997 (6) |
8/79 (10.1%) |
|
Sano et al, 1998 (8) |
1/39 (2.8%) |
|
Klaes et al, 2001 (9) |
1/53 (1.9%) |
|
Sano et al, 2002 (12) |
0/34 (0%) |
|
Klaes et al, 2002 (4) |
0/46 (0%) |
|
Saqi et al, 2002 (13) |
0/1 (0 %) |
|
Murphy et al, 2003 (14) |
0/8 (0%) |
|
Agoff et al, 2003 (16) |
4/46 (8.7%) |
|
Present study |
1/21 (4.8%) |
|
|
|
|
Volgareva et al. BMC Cancer 2004 4:58 doi:10.1186/1471-2407-4-58 |
|
